Matches in Wikidata for { <http://www.wikidata.org/entity/Q37300368> ?p ?o ?g. }
- Q37300368 description "article científic" @default.
- Q37300368 description "article scientifique" @default.
- Q37300368 description "articolo scientifico" @default.
- Q37300368 description "artigo científico" @default.
- Q37300368 description "artículu científicu espublizáu en 2013" @default.
- Q37300368 description "bilimsel makale" @default.
- Q37300368 description "scientific article published on 19 June 2013" @default.
- Q37300368 description "vedecký článok" @default.
- Q37300368 description "vetenskaplig artikel" @default.
- Q37300368 description "videnskabelig artikel" @default.
- Q37300368 description "vědecký článek" @default.
- Q37300368 description "wetenschappelijk artikel" @default.
- Q37300368 description "wissenschaftlicher Artikel" @default.
- Q37300368 description "наукова стаття, опублікована в червні 2013" @default.
- Q37300368 description "научни чланак" @default.
- Q37300368 description "مقالة علمية نشرت في 19 يونيو 2013" @default.
- Q37300368 name "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)." @default.
- Q37300368 name "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)." @default.
- Q37300368 name "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL" @default.
- Q37300368 type Item @default.
- Q37300368 label "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)." @default.
- Q37300368 label "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)." @default.
- Q37300368 label "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL" @default.
- Q37300368 prefLabel "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)." @default.
- Q37300368 prefLabel "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)." @default.
- Q37300368 prefLabel "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL" @default.
- Q37300368 P1433 Q37300368-949F973B-B427-4014-B496-44361551364E @default.
- Q37300368 P1476 Q37300368-C8BEE2FC-5931-4B0D-B1DE-02FA32876465 @default.
- Q37300368 P2093 Q37300368-3601F1F2-AF53-4954-9177-FD65EB33F93A @default.
- Q37300368 P2093 Q37300368-575118EC-04E9-43D2-9F4D-76A99D381C5C @default.
- Q37300368 P2093 Q37300368-8CB405DF-D7B6-4DB2-A7F4-5D3EEBF56CAA @default.
- Q37300368 P2093 Q37300368-D75353CD-083A-49FD-B54E-4D702FF84CB8 @default.
- Q37300368 P2093 Q37300368-DAD50AEF-7D7E-4A83-B344-909EC9907220 @default.
- Q37300368 P2093 Q37300368-FCF7A564-19F4-49A3-9622-C058EF7CDEDD @default.
- Q37300368 P275 Q37300368-06acfe8f-4b3b-4ddc-94c6-2c06ac60a92d @default.
- Q37300368 P2860 Q37300368-06983E92-A0D8-4BE6-A7FD-FE2FD8D430D1 @default.
- Q37300368 P2860 Q37300368-0CC4DB0F-7E78-4A53-AF8F-F6563F5DE451 @default.
- Q37300368 P2860 Q37300368-0F9CBB91-7CDE-4BF2-BA34-C67B9866D85E @default.
- Q37300368 P2860 Q37300368-13DD6244-E17E-47E8-A29F-0F2DF9147A05 @default.
- Q37300368 P2860 Q37300368-23922126-C390-47E4-95F2-E0A3D5029479 @default.
- Q37300368 P2860 Q37300368-280FFAB7-0FB3-47AE-A394-EF4A40E7A602 @default.
- Q37300368 P2860 Q37300368-392B218B-5FA4-4FFB-902E-D565B8EC78ED @default.
- Q37300368 P2860 Q37300368-44DEFB20-BCC1-437C-807C-B2093AF148EC @default.
- Q37300368 P2860 Q37300368-48B17D59-1033-4E31-B15B-545BFBAF60B5 @default.
- Q37300368 P2860 Q37300368-5A34259B-FDE5-4BC3-9B9C-1F5C70DE1310 @default.
- Q37300368 P2860 Q37300368-5C69A750-CC32-4A70-A2D8-1A2211C6BFC5 @default.
- Q37300368 P2860 Q37300368-5E814FB3-775E-473A-938C-B598EA9DA917 @default.
- Q37300368 P2860 Q37300368-6301C819-21B1-41B7-A568-157A279C85DA @default.
- Q37300368 P2860 Q37300368-65391BFE-8B08-4399-AD07-202884E4BA15 @default.
- Q37300368 P2860 Q37300368-66E441B3-9C6E-4785-B3BA-665C083E6BFC @default.
- Q37300368 P2860 Q37300368-6A7823FB-1DEF-4386-9F47-355E2324729A @default.
- Q37300368 P2860 Q37300368-725AB14C-CF23-4F57-A212-491CC8564355 @default.
- Q37300368 P2860 Q37300368-79D830F2-3D0B-453F-87F3-F88B1E9DA12C @default.
- Q37300368 P2860 Q37300368-7C719483-F603-4D28-8B05-B12E3CDE27C8 @default.
- Q37300368 P2860 Q37300368-7DFAD14A-9372-4F36-AFD7-5CDC8CC4E774 @default.
- Q37300368 P2860 Q37300368-80031564-E323-49D4-B35E-EC08C10A4C8E @default.
- Q37300368 P2860 Q37300368-80B17C74-0EA7-4D52-B358-FA0592A698A5 @default.
- Q37300368 P2860 Q37300368-82A7E0E7-943C-4F65-B565-2DF3805ACF0F @default.
- Q37300368 P2860 Q37300368-8962C3E2-09E8-4BEF-A4EE-156451552ED2 @default.
- Q37300368 P2860 Q37300368-906931DF-A65A-4953-B723-BD57519D84EC @default.
- Q37300368 P2860 Q37300368-91EB3D17-F4CF-4FC1-8FA8-33609CF6F511 @default.
- Q37300368 P2860 Q37300368-9298E87A-3E06-42D1-A4D5-95C740BEBDF9 @default.
- Q37300368 P2860 Q37300368-9E8C5220-838A-4A4E-A2AC-8E38C5858B60 @default.
- Q37300368 P2860 Q37300368-9EFBD494-27B8-44A9-B602-07500D5B5B22 @default.
- Q37300368 P2860 Q37300368-A5EA7B86-D39B-49DC-9E80-56C1EB2A2C8C @default.
- Q37300368 P2860 Q37300368-A6AEC7EB-2847-43B7-8DCA-DA02687D1C68 @default.
- Q37300368 P2860 Q37300368-B2834F05-D224-4EEC-A8C4-BF95FF33599B @default.
- Q37300368 P2860 Q37300368-C09E3315-5634-42DC-8092-929B3A627404 @default.
- Q37300368 P2860 Q37300368-D4E52364-05AC-427F-A946-8D48BBAB6718 @default.
- Q37300368 P2860 Q37300368-D6DF6717-9446-4AA2-AF96-91166E843ED0 @default.
- Q37300368 P2860 Q37300368-DAC617BD-4BCF-4796-BDDD-B2F91A7367B7 @default.
- Q37300368 P2860 Q37300368-DC920B21-440A-4493-A7BC-FF20CF6735CF @default.
- Q37300368 P2860 Q37300368-DE5F60CC-341A-4DFC-B82D-EC7D45F19E74 @default.
- Q37300368 P2860 Q37300368-ED2945AE-A3D8-4C8E-8A03-E4BEEF0051EC @default.
- Q37300368 P2860 Q37300368-F024F956-7F49-4BC2-ABC8-2E89EC26870C @default.
- Q37300368 P2860 Q37300368-FD1CB2D1-4627-4B39-A152-F0223B240E8C @default.
- Q37300368 P2888 Q37300368-7A7B8E6A-61EF-4FC3-9DF2-4E202FC548D4 @default.
- Q37300368 P304 Q37300368-68000BBC-4108-4251-A059-A01635162E80 @default.
- Q37300368 P31 Q37300368-D4E9C105-41FA-45FC-BD2D-220C5DFF036D @default.
- Q37300368 P356 Q37300368-8C391F5C-01ED-4D30-BD5D-AEC02F4C9D6D @default.
- Q37300368 P433 Q37300368-F7A35DF5-D742-4DDA-97C8-75D7C82EA8D8 @default.
- Q37300368 P478 Q37300368-AC40E134-B559-4EB2-A790-50C195C075B1 @default.
- Q37300368 P50 Q37300368-D66FB975-81A3-43CC-9D7D-01D3B4CFDEAE @default.
- Q37300368 P577 Q37300368-D2F3FEA7-791C-4F33-92B8-7AF61AAC4F89 @default.
- Q37300368 P5875 Q37300368-CD16509A-758F-49A0-ADD1-7A21C3F58BEB @default.
- Q37300368 P6179 Q37300368-BA9B55D1-F3CC-45BA-A994-EE3198BDD1B9 @default.
- Q37300368 P6216 Q37300368-1cd75c96-24df-4d0b-91dd-22a896ee65c4 @default.
- Q37300368 P698 Q37300368-74C61285-A118-47B7-9DD6-E6A6A1E4CF53 @default.
- Q37300368 P921 Q37300368-8A78637E-2A5E-4214-8D49-24FC4BC6B178 @default.
- Q37300368 P921 Q37300368-B2A3058A-75F7-481E-BC7B-1CD2D6FDB696 @default.
- Q37300368 P932 Q37300368-43085D1B-4415-4432-BA46-17ABB43661E2 @default.
- Q37300368 P356 S10434-013-3038-Y @default.
- Q37300368 P698 23780381 @default.
- Q37300368 P1433 Q2853069 @default.
- Q37300368 P1476 "Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)." @default.
- Q37300368 P2093 "Christina Yau" @default.
- Q37300368 P2093 "I-SPY 1 TRIAL and ACRIN 6657 Investigators" @default.
- Q37300368 P2093 "Mark Rosen" @default.
- Q37300368 P2093 "Nola Hylton" @default.
- Q37300368 P2093 "Rita A Mukhtar" @default.